Black Rock Inc. Aurinia Pharmaceuticals Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,272,162 shares of AUPH stock, worth $75.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,272,162
Previous 8,662,978
7.03%
Holding current value
$75.3 Million
Previous $43.4 Million
21.99%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AUPH
# of Institutions
209Shares Held
58.7MCall Options Held
1.14MPut Options Held
1.51M-
Armistice Capital, LLC New York, NY8.2MShares$66.6 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$58.7 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32.2 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.9 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.41MShares$19.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.15B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...